Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Return on Assets: 2011-2025

Historic Return on Assets for Arrowhead Pharmaceuticals (ARWR) over the last 14 years, with Sep 2025 value amounting to 0.02%.

  • Arrowhead Pharmaceuticals' Return on Assets rose 62.00% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 62.00%. This contributed to the annual value of 0.02% for FY2025, which is 66.00% up from last year.
  • As of Q3 2025, Arrowhead Pharmaceuticals' Return on Assets stood at 0.02%, which was up 120.15% from -0.11% recorded in Q2 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' Return on Assets registered a high of 0.02% during Q3 2025, and its lowest value of -0.60% during Q1 2024.
  • Over the past 3 years, Arrowhead Pharmaceuticals' median Return on Assets value was -0.27% (recorded in 2023), while the average stood at -0.34%.
  • In the last 5 years, Arrowhead Pharmaceuticals' Return on Assets crashed by 43bps in 2024 and then surged by 62bps in 2025.
  • Arrowhead Pharmaceuticals' Return on Assets (Quarterly) stood at -0.27% in 2021, then increased by 8bps to -0.20% in 2022, then dropped by 24bps to -0.44% in 2023, then decreased by 17bps to -0.60% in 2024, then surged by 62bps to 0.02% in 2025.
  • Its last three reported values are 0.02% in Q3 2025, -0.11% for Q2 2025, and -0.12% during Q1 2025.